Zimmer Biomet Holdings Past Earnings Performance
Past criteria checks 1/6
Zimmer Biomet Holdings has been growing earnings at an average annual rate of 28.8%, while the Medical Equipment industry saw earnings growing at 13.3% annually. Revenues have been growing at an average rate of 2.8% per year. Zimmer Biomet Holdings's return on equity is 6.6%, and it has net margins of 10.5%.
Key information
28.80%
Earnings growth rate
29.39%
EPS growth rate
| Medical Equipment Industry Growth | 8.90% |
| Revenue growth rate | 2.76% |
| Return on equity | 6.59% |
| Net Margin | 10.51% |
| Last Earnings Update | 30 Jun 2025 |
Recent past performance updates
Recent updates
Here's Why Zimmer Biomet Holdings (NYSE:ZBH) Can Manage Its Debt Responsibly
Jul 22
Zimmer Biomet Q2 Preview: Combining Monogram Autonomous Robotics With ROSA
Jul 21Many Still Looking Away From Zimmer Biomet Holdings, Inc. (NYSE:ZBH)
Jul 04Zimmer Biomet Holdings (NYSE:ZBH) Is Paying Out A Dividend Of $0.24
Jun 16Zimmer Biomet Holdings' (NYSE:ZBH) Dividend Will Be $0.24
Jun 02Zimmer Biomet Holdings (NYSE:ZBH) Shareholders Will Want The ROCE Trajectory To Continue
May 27Some May Be Optimistic About Zimmer Biomet Holdings' (NYSE:ZBH) Earnings
May 12An Intrinsic Calculation For Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Suggests It's 39% Undervalued
Apr 09Zimmer Biomet Holdings (NYSE:ZBH) Has Announced A Dividend Of $0.24
Mar 15Zimmer Biomet Holdings (NYSE:ZBH) Has Announced A Dividend Of $0.24
Mar 01Zimmer Biomet: Adding To The Growth Profile
Feb 07Investors Appear Satisfied With Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) Prospects
Feb 06These 4 Measures Indicate That Zimmer Biomet Holdings (NYSE:ZBH) Is Using Debt Reasonably Well
Jan 10Zimmer Biomet: Back On Offense With Strong Cash Flow Outlook
Jan 05Zimmer Biomet Holdings (NYSE:ZBH) Is Due To Pay A Dividend Of $0.24
Dec 21At US$108, Is It Time To Put Zimmer Biomet Holdings, Inc. (NYSE:ZBH) On Your Watch List?
Dec 08Shareholders Can Be Confident That Zimmer Biomet Holdings' (NYSE:ZBH) Earnings Are High Quality
Nov 07Results: Zimmer Biomet Holdings, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates
Nov 02Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) Share Price Not Quite Adding Up
Oct 03Zimmer Biomet: The Undervalued Titan Of Joint Replacements
Oct 02Zimmer Biomet Stock: Don't Jump In At The 52-Week Low
Sep 19We Like These Underlying Return On Capital Trends At Zimmer Biomet Holdings (NYSE:ZBH)
Sep 18Zimmer Biomet: Brighter Prospects In H2 2024
Jul 02Zimmer Biomet Holdings: Moving Along
May 17Revenue & Expenses Breakdown
How Zimmer Biomet Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 25 | 7,834 | 824 | 2,972 | 444 |
| 31 Mar 25 | 7,699 | 913 | 2,898 | 440 |
| 31 Dec 24 | 7,679 | 904 | 2,876 | 437 |
| 30 Sep 24 | 7,596 | 1,084 | 2,856 | 442 |
| 30 Jun 24 | 7,525 | 997 | 2,822 | 448 |
| 31 Mar 24 | 7,452 | 964 | 2,816 | 456 |
| 31 Dec 23 | 7,394 | 1,024 | 2,793 | 459 |
| 30 Sep 23 | 7,279 | 474 | 2,768 | 453 |
| 30 Jun 23 | 7,196 | 506 | 2,757 | 438 |
| 31 Mar 23 | 7,108 | 450 | 2,727 | 420 |
| 31 Dec 22 | 6,940 | 290 | 2,668 | 406 |
| 30 Sep 22 | 6,892 | 366 | 2,649 | 394 |
| 30 Jun 22 | 6,908 | 334 | 2,632 | 386 |
| 31 Mar 22 | 6,889 | 325 | 2,631 | 452 |
| 31 Dec 21 | 6,827 | 445 | 2,626 | 436 |
| 30 Sep 21 | 7,135 | 834 | 2,787 | 440 |
| 30 Jun 21 | 7,379 | 914 | 2,915 | 432 |
| 31 Mar 21 | 6,842 | 563 | 2,886 | 355 |
| 31 Dec 20 | 6,128 | -11 | 2,524 | 323 |
| 30 Sep 20 | 7,065 | -152 | 3,030 | 393 |
| 30 Jun 20 | 7,028 | 37 | 3,042 | 422 |
| 31 Mar 20 | 7,791 | 377 | 3,221 | 446 |
| 31 Dec 19 | 7,982 | 1,132 | 3,279 | 449 |
| 30 Sep 19 | 7,928 | -90 | 3,331 | 429 |
| 30 Jun 19 | 7,872 | -359 | 3,299 | 411 |
| 31 Mar 19 | 7,891 | -308 | 3,268 | 398 |
| 31 Dec 18 | 7,933 | -379 | 3,372 | 392 |
| 30 Sep 18 | 7,930 | 1,753 | 3,119 | 386 |
| 30 Jun 18 | 7,907 | 1,690 | 3,071 | 381 |
| 31 Mar 18 | 7,849 | 1,689 | 3,029 | 375 |
| 31 Dec 17 | 7,803 | 1,814 | 3,096 | 370 |
| 30 Sep 17 | 7,748 | 652 | 2,988 | 371 |
| 30 Jun 17 | 7,768 | 712 | 3,012 | 375 |
| 31 Mar 17 | 7,752 | 497 | 2,972 | 371 |
| 31 Dec 16 | 7,668 | 306 | 2,906 | 366 |
| 30 Sep 16 | 7,604 | 363 | 2,900 | 356 |
| 30 Jun 16 | 7,534 | 227 | 2,865 | 344 |
| 31 Mar 16 | 6,767 | 84 | 2,577 | 306 |
| 31 Dec 15 | 5,998 | 147 | 2,284 | 269 |
| 30 Sep 15 | 5,287 | 174 | 2,000 | 229 |
| 30 Jun 15 | 4,631 | 325 | 1,730 | 192 |
| 31 Mar 15 | 4,646 | 670 | 1,730 | 188 |
| 31 Dec 14 | 4,673 | 720 | 1,751 | 187 |
| 30 Sep 14 | 4,691 | 802 | 1,789 | 188 |
Quality Earnings: ZBH has a large one-off loss of $304.6M impacting its last 12 months of financial results to 30th June, 2025.
Growing Profit Margin: ZBH's current net profit margins (10.5%) are lower than last year (13.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ZBH's earnings have grown significantly by 28.8% per year over the past 5 years.
Accelerating Growth: ZBH's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: ZBH had negative earnings growth (-17.4%) over the past year, making it difficult to compare to the Medical Equipment industry average (12.6%).
Return on Equity
High ROE: ZBH's Return on Equity (6.6%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/09/12 17:55 |
| End of Day Share Price | 2025/09/12 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Zimmer Biomet Holdings, Inc. is covered by 63 analysts. 26 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| David Toung | Argus Research Company |
| Stephan Gasteyger | Atlantic Equities LLP |
| Jeffrey Johnson | Baird |